Elizabeth Crowley
Net Worth

Last updated:

What is Elizabeth Crowley net worth?

The estimated net worth of Ms. Elizabeth Crowley is at least $5,431,333 as of 14 Jun 2024. She owns shares worth $186,743 as insider, has earned $3,215,630 from insider trading and has received compensation worth at least $2,028,960 in Celldex Therapeutics, Inc..

What is the salary of Elizabeth Crowley?

Ms. Elizabeth Crowley salary is $507,240 per year as Chief Product Devel. Officer & Senior Vice President in Celldex Therapeutics, Inc..

How old is Elizabeth Crowley?

Ms. Elizabeth Crowley is 53 years old, born in 1972.

What stocks does Elizabeth Crowley currently own?

As insider, Ms. Elizabeth Crowley owns shares in one company:

Company Title Shares Price per share Total value
Celldex Therapeutics, Inc. (CLDX) Chief Product Devel. Officer & Senior Vice President 9,074 $20.58 $186,743

What does Celldex Therapeutics, Inc. do?

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX logo
CLDX
Celldex Therapeutics, Inc.
$20.58

Elizabeth Crowley insider trading

Celldex Therapeutics, Inc.

Ms. Elizabeth Crowley has made 5 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently she sold 30,000 units of CLDX stock worth $1,045,950 on 14 Jun 2024.

The largest trade she's ever made was exercising 38,597 units of CLDX stock on 30 May 2024. As of 14 Jun 2024 she still owns at least 9,074 units of CLDX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 30,000 $34.87 $1,045,950
Option
Common Stock 30,000 $10.38 $311,400
Option
Incentive Stock Option (Right to Buy) 30,000 $10.38 $311,400
Sale
Common Stock 15,000 $35.06 $525,870
Option
Incentive Stock Option (Right to Buy) 7,500 $9.02 $67,628
Option
Incentive Stock Option (Right to Buy) 7,500 $10.38 $77,850
Option
Common Stock 7,500 $10.38 $77,850
Option
Common Stock 7,500 $9.02 $67,628
Option
Incentive Stock Option (Right to Buy) 8,500 $9.02 $76,645
Option
Common Stock 34,445 $2.78 $95,757
Option
Incentive Stock Option (Right to Buy) 34,445 $2.78 $95,757
Option
Common Stock 8,500 $9.02 $76,645
Sale
Common Stock 38,597 $33.64 $1,298,403
Option
Incentive Stock Option (Right to Buy) 4,000 $9.02 $36,068
Sale
Common Stock 4,000 $40 $160,000
Option
Common Stock 4,000 $9.02 $36,068
Option
Incentive Stock Option (Right to Buy) 8,555 $2.78 $23,783
Sale
Common Stock 4,317 $42.95 $185,407
Option
Common Stock 8,555 $2.78 $23,783

Celldex Therapeutics key executives

Celldex Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Margo Heath-Chiozzi M.D. (68) Senior Vice President of Regulatory Affairs
  • Dr. Tibor Keler (66) Founder, Chief Scientific Officer & Executive Vice President
  • Mr. Anthony S. Marucci M.B.A. (63) Founder, Pres, Chief Executive Officer & Director
  • Mr. Sam Martin (54) Senior Vice President, Chief Financial Officer, Sec. & Treasurer
  • Ms. Elizabeth Crowley (53) Chief Product Devel. Officer & Senior Vice President